Top

Cost Effectiveness and Resource Allocation

Published in:

Open Access 01-12-2023 | Heart Failure | Research

Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis

Authors: Tianyi Liu, Yiyang Zhan, Silei Chen, Wenhong Zhang, Jian Jia

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2023

Abstract

Background

In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital technologies and products in cardiac rehabilitation. Digital therapeutics (DTx) is an evidence-based medicine that uses digital means for data collection and monitoring of indicators to control and optimize the treatment, management, and prevention of disease.

Objective

This study collected and reviewed real-world data and built a model using health economics assessment methods to analyze the potential cost-effectiveness of DTx applied to home-based cardiac rehabilitation for patients with chronic heart failure. From the perspective of medical and health decision-makers, the economic value of DTx is evaluated prospectively to provide the basis and reference for the application decision and promotion of DTx.

Methods

Markov models were constructed to simulate the outcomes of DTx for home-based cardiac rehabilitation (DT group) compared to conventional home-based cardiac rehabilitation (CH group) in patients with chronic heart failure. The model input parameters were clinical indicators and cost data. Outcome indicators were quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). The robustness of the evaluation methods and results was tested using sensitivity analyses. Clinical indicators, cost data, and health utility values were obtained from real-world data, including clinical study data, published literature, and public website information.

Results

The Markov model simulated a time span of 10 years, with a cycle set at one month, for 120 cycles. The results showed that the per capita cost of the CH group was 38,442.11 CNY/year, with a QALY of 0.7196 per person per year. The per capita cost of the DT group was 42,300.26 CNY/year, with a QALY of 0.81687 per person per year. The ICER per person was 39,663.5 CNY/QALY each year, which was below the willingness-to-pay threshold of 85,698 CNY (China's GDP per capita in 2022).

Conclusions

DTx for home-based cardiac rehabilitation is an extremely cost-effective rehabilitation option compared with conventional home-based cardiac rehabilitation. DTx for home-based cardiac rehabilitation is potentially valuable from the perspective of healthcare decision-makers.

Bozkurt B, Coats A, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Zieroth S. Universal definition and classification of heart failure: a report of the heart failure society of america, heart failure association of the european society of cardiology, japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and New Zealand, and Chinese heart failure association. Eur J Heart Failure. 2021;23(3):352–80. https://doi.org/10.1002/ejhf.2115.CrossRef

Braunwald E. The war against heart failure: the Lancet lecture. Lancet. 2015;385(9970):812–24. https://doi.org/10.1016/S0140-6736(14)61889-4.CrossRefPubMed

Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D, Framingham Heart Study. Lifetime risk for developing congestive heart failure: the framingham heart study. Circulation. 2002;106(24):3068–72. https://doi.org/10.1161/01.cir.0000039105.49749.6f.CrossRefPubMed

Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, EuroHeart Survey Investigators, & Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725–36. https://doi.org/10.1093/eurheartj/ehl193.CrossRefPubMed

Zhang J, Zhang YH. Multicenter, prospective Chinese heart failure registry study - preliminary analysis of etiology, clinical characteristics and treatment[J]. Chinese J of Circ. 2015;30(5):4.

Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J., Coats, A., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A. ESC Scientific Document Group (2022) (2022). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. European journal of heart failure, 24(1), 4–131. https://doi.org/10.1002/ejhf.2333

Chinese guidelines for the diagnosis and treatment of heart failure 2018. (2018). Chinese Journal of Heart Failure and Cardiomyopathy (04), 196–225.

Chinese expert consensus on cardiac rehabilitation in chronic heart failure[J]. Chinese Journal of Internal Medicine,2020,59(12):942–952.

AACVPR. Guidelines for Cardiac Rehabilitation Programs (6th Edition) [M]. Champaign: Human Kinetics, 2021.

10.

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G. A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J. P., Lettino, M., Lip, G., Pinto, F. J., Thomas, G. N. ESC Scientific Document Group (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European heart journal. 42(5), 373–498. https://doi.org/10.1093/eurheartj/ehaa612

11.

Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54(1):25–33. https://doi.org/10.1016/j.jacc.2009.01.078.CrossRefPubMed

12.

Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly medicare beneficiaries. Circulation. 2010;121(1):63–70. https://doi.org/10.1161/CIRCULATIONAHA.109.876383.CrossRefPubMed

13.

Cardiovascular Disease Specialized Committee of the Chinese Society of Rehabilitation Medicine. Chinese cardiac rehabilitation and secondary prevention guidelines 2018 concise summary. Chinese J Int Med. 2018;57(11):9.

14.

Giannuzzi P, Temporelli PL, Corrà U, Tavazzi L, ELVD-CHF Study Group. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) Trial. Circulation. 2003;108(5):554–9. https://doi.org/10.1161/01.CIR.0000081780.38477.CrossRefPubMed

15.

Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, Franklin BA, Keteyian SJ, Kitzman DW, Regensteiner JG, Sanderson BK, Whooley MA. Home-based cardiac rehabilitation: a scientific statement from the american association of cardiovascular and pulmonary rehabilitation, the american heart association, and the american college of cardiology. Circulation. 2019;140(1):e69–89. https://doi.org/10.1161/CIR.0000000000000663.CrossRefPubMed

16.

Scalvini S, Zanelli E, Comini L, Tomba MD, Troise G, Giordano A. Home-based exercise rehabilitation with telemedicine following cardiac surgery. J Telemed Telecare. 2009;15(6):297–301. https://doi.org/10.1258/jtt.2009.090208.CrossRefPubMed

17.

Piotrowicz E, Korzeniowska-Kubacka I, Chrapowicka A, Wolszakiewicz J, Dobraszkiewicz-Wasilewska B, Batogowski M, Piotrowski W, Piotrowicz R. Feasibility of home-based cardiac telerehabilitation: Results of TeleInterMed study. Cardiol J. 2014;21(5):539–46. https://doi.org/10.5603/CJ.a2014.0005.CrossRefPubMed

18.

Chien CL, Lee CM, Wu YW, Wu YT. Home-based exercise improves the quality of life and physical function but not the psychological status of people with chronic heart failure: a randomised trial. J Physiother. 2011;57(3):157–63. https://doi.org/10.1016/S1836-9553(11)70036-4.CrossRefPubMed

19.

Peng X, Su Y, Hu Z, Sun X, Li X, Dolansky MA, Qu M, Hu X. Home-based telehealth exercise training program in Chinese patients with heart failure: a randomized controlled trial. Medicine. 2018;97(35):e12069. https://doi.org/10.1097/MD.0000000000012069.CrossRefPubMedPubMedCentral

20.

JK RD, Liguori G, Magal M. (2018). ACSM’s guidelines for exercise testing and pre-scription (10th Edition).

21.

Imran HM, Baig M, Erqou S, Taveira TH, Shah NR, Morrison A, Choudhary G, Wu WC. Home-based cardiac rehabilitation alone and hybrid with center-based cardiac rehabilitation in heart failure: a systematic review and meta-analysis. J Am Heart Assoc. 2019;8(16):e012779. https://doi.org/10.1161/JAHA.119.012779.CrossRefPubMedPubMedCentral

22.

Jiang X, Yao J, You JH. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis. J Med Internet Res. 2021;23(3):e26516. https://doi.org/10.2196/26516.CrossRefPubMedPubMedCentral

23.

Okwose NC, O’Brien N, Charman S, Cassidy S, Brodie D, Bailey K, MacGowan GA, Jakovljevic DG, Avery L. Overcoming barriers to engagement and adherence to a home-based physical activity intervention for patients with heart failure: a qualitative focus group study. BMJ Open. 2020;10(9):e036382. https://doi.org/10.1136/bmjopen-2019-036382.CrossRefPubMedPubMedCentral

24.

Brouwers RWM, Brini A. Robin Wilhelmus Franciscus Henricus Kuijpers, Jozua Johannes Kraal, Hareld Marijn Clemens Kemps, Predictors of non-participation in a cardiac telerehabilitation programme: a prospective analysis, European Heart Journal - Digital. Health. 2022;3(1):81–9. https://doi.org/10.1093/ehjdh/ztab105.CrossRef

25.

Falter M, Scherrenberg M, Kindermans H, Kizilkilic S, Kaihara T, Dendale P. Willingness to participate in cardiac telerehabilitation: results from semi-structured interviews. Eur Heart J Digit Health. 2022;3(1):67–76. https://doi.org/10.1093/ehjdh/ztab091.CrossRefPubMed

26.

Grustam AS, Severens JL, De Massari D, Buyukkaramikli N, Koymans R, Vrijhoef H. Cost-effectiveness analysis in telehealth: a comparison between home telemonitoring, nurse telephone support, and usual care in chronic heart failure management. Value Health. 2018;21(7):772–82. https://doi.org/10.1016/j.jval.2017.11.011.CrossRefPubMed

27.

Ware P, Ross HJ, Cafazzo JA, Boodoo C, Munnery M, Seto E. Outcomes of a heart failure telemonitoring program implemented as the standard of care in an outpatient heart function clinic: pretest-posttest pragmatic study. J Med Internet Res. 2020;22(2):e16538. https://doi.org/10.2196/16538.CrossRefPubMedPubMedCentral

28.

Boodoo C, Zhang Q, Ross HJ, Alba AC, Laporte A, Seto E. Evaluation of a heart failure telemonitoring program through a microsimulation model: cost-utility analysis. J Med Internet Res. 2020;22(10):e18917. https://doi.org/10.2196/18917.CrossRefPubMedPubMedCentral

29.

Ware P, Dorai M, Ross HJ, Cafazzo JA, Laporte A, Boodoo C, Seto E. Patient adherence to a mobile phone-based heart failure telemonitoring program: a longitudinal mixed-methods study. JMIR Mhealth Uhealth. 2019;7(2):e13259. https://doi.org/10.2196/13259.CrossRefPubMedPubMedCentral

30.

Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH, Investigators TEN-HMS. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005;45(10):1654–64. https://doi.org/10.1016/j.jacc.2005.01.050.CrossRefPubMed

31.

Digital Therapeutics Alliance. DTx Value Assessment & Integration Guide (Version 2.0). (2022)

32.

Moravcová K, Karbanová M, Bretschneider MP, Sovová M, Ožana J, Sovová E. Comparing digital therapeutic intervention with an intensive obesity management program: randomized controlled trial. Nutrients. 2022;14(10):2005. https://doi.org/10.3390/nu14102005.CrossRefPubMedPubMedCentral

33.

Kim M, Choi HJ. Digital therapeutics for obesity and eating-related problems. Endocrinol metab. 2021;36(2):220–8. https://doi.org/10.3803/EnM.2021.107.CrossRef

34.

Ritterband LM, Thorndike FP, Morin CM, Gerwien R, Enman NM, Xiong R, Luderer HF, Edington S, Braun S, Maricich YA. Real-world evidence from users of a behavioral digital therapeutic for chronic insomnia. Behav Res Ther. 2022;153:104084. https://doi.org/10.1016/j.brat.2022.104084.CrossRefPubMed

35.

Lewkowicz D, Wohlbrandt AM, Bottinger E. Digital therapeutic care apps with decision-support interventions for people with low back pain in Germany: cost-effectiveness analysis. JMIR Mhealth Uhealth. 2022;10(2):e35042. https://doi.org/10.2196/35042.CrossRefPubMedPubMedCentral

36.

Xiao S, Angjeli E, Wu HC, Gaier ED, Gomez S, Travers DA, Binenbaum G, Langer R, Hunter DG, Repka MX, Luminopia Pivotal Trial Group. Randomized controlled trial of a dichoptic digital therapeutic for amblyopia. Ophthalmology. 2022;129(1):77–85. https://doi.org/10.1016/j.ophtha.2021.09.001.CrossRefPubMed

37.

Gilson A, Gassman M, Dodds D, Lombardo R, Ford Ii JH, Potteiger M. Refining a digital therapeutic platform for home care agencies in dementia care to elicit stakeholder feedback: focus group study with stakeholders. JMIR aging. 2022;5(1):e32516. https://doi.org/10.2196/32516.CrossRefPubMedPubMedCentral

38.

Fortune DG, Ravnkilde V, Ryan S, Ramsay B, Clough S, Richards HL. A digital therapeutic for management of psychosocial aspects of psoriasis: A pre-post proof of concept study. Skin health Dis. 2022;2(2):e103. https://doi.org/10.1002/ski2.103.CrossRefPubMedPubMedCentral

39.

Kario K, Harada N, Okura A. Digital therapeutics in hypertension: evidence and perspectives. Hypertension. 2022;79(10):2148–58. https://doi.org/10.1161/HYPERTENSIONAHA.122.19414.CrossRefPubMed

40.

Li Y, Gong Y, Zheng B, Fan F, Yi T, Zheng Y, He P, Fang J, Jia J, Zhu Q, Jiang J, Huo Y. Effects on adherence to a mobile app-based self-management digital therapeutics among patients with coronary heart disease: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2022;10(2):e32251. https://doi.org/10.2196/32251.CrossRefPubMedPubMedCentral

41.

Kawasaki S, Mills-Huffnagle S, Aydinoglo N, Maxin H, Nunes E. Patient- and provider-reported experiences of a mobile novel digital therapeutic in people with opioid use disorder (reSET-O): feasibility and acceptability study. JMIR Formative Res. 2022;6(3):e33073. https://doi.org/10.2196/33073.CrossRef

42.

Bao ZP, Sun GZ, Wang J, et al. Impact of multimodal home care based on digital platform on sleep quality in patients with atrial fibrillation after radiofrequency ablation. Journal of Nurse Advancement. 2021;36(16):1468–71.

43.

Lear SA. The delivery of cardiac rehabilitation using communications technologies: the “virtual” cardiac rehabilitation program. Can J Cardiol. 2018;34(10 Suppl 2):S278–83. https://doi.org/10.1016/j.cjca.2018.07.009.CrossRefPubMed

44.

Chen YW, Wang CY, Lai YH, Liao YC, Wen YK, Chang ST, Huang JL, Wu TJ. Home-based cardiac rehabilitation improves quality of life, aerobic capacity, and readmission rates in patients with chronic heart failure. Medicine. 2018;97(4):e9629. https://doi.org/10.1097/MD.0000000000009629.CrossRefPubMedPubMedCentral

45.

Hong JS, Wasden C, Han DH. Introduction of digital therapeutics. Comput Methods Programs Biomed. 2021;209:106319. https://doi.org/10.1016/j.cmpb.2021.106319.CrossRefPubMed

46.

Rassi-Cruz M, Valente F, Caniza MV. Digital therapeutics and the need for regulation: how to develop products that are innovative, patient-centric and safe. Diabetol Metab Syndr. 2022;14(1):48. https://doi.org/10.1186/s13098-022-00818-9.CrossRefPubMedPubMedCentral

47.

Caro JJ, Briggs AH, Siebert U, Kuntz KM, ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Med Decis Making. 2012;32(5):667–77. https://doi.org/10.1177/0272989X12454577.CrossRefPubMed

48.

Liu G. E., Hu S. L., et al. Guide to pharmacoeconomic evaluation in China (2020 edition) [M]. China Market Press, (2020).

49.

iResearch Inc. . China Smart Sports & Fitness Industry Research Report 2021. (2021).

50.

Nanjing City issues price policy for family doctor contracted service items. Health Commission of Nanjing. http://wjw.nanjing.gov.cn/njswshjhsywyh/201810/t20181023_642810.html. Accessed 23 Oct 2018.

51.

Xuan JW, Tao LB, Zhu S, Zhang ML, Ni B, Qiao S, Shanlian Hu. A real-world study of non-direct medical costs and patient quality of life of heart failure patients in China. China Health Insurance. 2017;03:61–4.

52.

Thokala P, Dodd P, Baalbaki H, Brennan A, Dixon S, Lowrie K. Developing markov models from real-world data: a case study of heart failure modeling using administrative data. Value Health. 2020;23(6):743–50. https://doi.org/10.1016/j.jval.2020.02.012.CrossRefPubMed

53.

The World Health Report 2002: reducing risks, promoting healthy life. World Health Organization. 2002.

54.

Xuan JW, Zhu S, Wang S, Sun Q, Tao LB, Hu S. Survey on hospitalization cost of heart failure patients in first-tier cities in China and analysis of its influencing factors. China Health Insurance. 2017;12:5.

55.

Yun JE, Park JE, Park HY, Lee HY, Park DA. Comparative effectiveness of telemonitoring versus usual care for heart failure: a systematic review and meta-analysis. J Cardiac Fail. 2018;24(1):19–28. https://doi.org/10.1016/j.cardfail.2017.09.006.CrossRef

56.

Thompson PD, Arena R, Riebe D, Pescatello LS. ACSM’s new preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription ninth edition. Curr Sports Med Rep. 2013;12(4):215–7. https://doi.org/10.1249/JSR.0b013e31829a68cf.CrossRefPubMed

Title: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis
Authors: Tianyi Liu
Yiyang Zhan
Silei Chen
Wenhong Zhang
Jian Jia
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Heart Failure
Chronic Heart Failure
Published in: Cost Effectiveness and Resource Allocation / Issue 1/2023
Electronic ISSN: 1478-7547
DOI: https://doi.org/10.1186/s12962-023-00489-x

At a glance: The STEP trials

Springer Medicine

Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis

Abstract

Background

Objective

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

The impact of government subsidy programs on equity in health financing

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting

Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?

Resource allocation in public sector programmes: does the value of a life differ between governmental departments?

Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial

Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.